Live Breaking News & Updates on Naoki Okumura At Doshisha University

Stay updated with breaking news from Naoki okumura at doshisha university. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Arctic Vision announces exclusive licensing agreement with ActualEyes

Arctic Vision announces exclusive licensing agreement with ActualEyes
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Hong Kong , South Korea , Shigeru Koizumi , Iku Sugioka , Kohsaku Imai , Naoki Okumura , Noriko Koizumi , Naoki Okumura At Doshisha University , Greater China , Arctic Vision , New England Journal , Board Director , Chief Executive Officer , Cultured Cells , New England , Five Year Follow Up , First Eleven Cases Undergoing Injection , Cultured Corneal Endothelial Cells , Corneal Endothelial , Professors Noriko Koizumi , Doshisha University , ஹாங் காங் , தெற்கு கொரியா , அதிகமானது சீனா , ஆர்க்டிக் பார்வை , புதியது இங்கிலாந்து இதழ் ,

Arctic Vision announces exclusive licensing agreement with ActualEyes

Arctic Vision announces exclusive licensing agreement with ActualEyes
News provided by
Share this article
Share this article
To develop and commercialize cell therapy to potentially replace corneal endothelial keratoplasty in Greater China and South Korea
Arctic Vision to partner with ActualEyes to introduce novel approach of using cultured corneal endothelial cells to treat corneal endothelial dysfunction and potentially replace corneal endothelial keratoplasty.
Under the terms of the agreement, the deal is worth up to more than USD 35 million, including upfront, regulatory milestone payments, and tiered royalties.
SHANGHAI, May 14, 2021 /PRNewswire/ Arctic Vision, a clinical stage biotech company focused on innovative ophthalmology therapies for pan-ocular diseases, and ActualEyes, a clinical stage Japanese biotech company committed to the research and development of cell therapy for corneal endothelial diseases, today jointly announced an exclusive ....

Shigeru Koizumi , Iku Sugioka , Kohsaku Imai , Naoki Okumura , Noriko Koizumi , Naoki Okumura At Doshisha University , New England Journal , Board Director , Arctic Vision , Chief Executive Officer , Cultured Cells , New England , Five Year Follow Up , First Eleven Cases Undergoing Injection , Cultured Corneal Endothelial Cells , Corneal Endothelial , Professors Noriko Koizumi , Doshisha University , புதியது இங்கிலாந்து இதழ் , பலகை இயக்குனர் , ஆர்க்டிக் பார்வை , தலைமை நிர்வாகி அதிகாரி , புதியது இங்கிலாந்து , தோஷிஷா பல்கலைக்கழகம் ,